Differences

This shows you the differences between two versions of the page.

--- amanda_cohn [2022/04/21 22:00]
liam [Centres for Disease Control and Prevention]
+++ amanda_cohn [2024/12/18 19:23] (current)
liam [COVID-19]
@@ Line 3: / Line 3: @@
 {{ ::capt-cohn.jpeg?200|}}
-Dr. **Amanda Cohn**, MD, is an American paediatrician based in [[united_states_of_america:georgia:Atlanta]], [[united states of america:Georgia]].
+Dr. **Amanda Cohn**, MD, is an American pediatrician based in [[united_states_of_america:georgia:Atlanta]], [[united states of america:Georgia]].
-===== Affiliations =====
+===== Education =====
-==== Centres for Disease Control and Prevention ====
+Cohn is board certified in Pediatrics and is a fellow of the [[American Academy of Pediatrics]].((//Fellows in the News.// (2014). AAP News, 35(7), 32–32. https://doi.org/10.1542/aapnews.2014357-32))
-Cohn is the Director of the Division of Birth Defects and Infant Disorders under the [[Center for Disease Control and Prevention|US Centers for Disease Control and Prevention]] (CDC).((CDC. (2021, December 17). //Amanda Cohn | Biographies | About Us | NCBDDD | CDC.// Centers for Disease Control and Prevention. https://archive.ph/bixnF)) She previously served as Executive Secretariat of the [[Advisory Committee on Immunization Practices]] (ACIP) and Chief Medical Officer for the [[National Center for Immunization and Respiratory Diseases]] (NCIRD).((//CAPT Amanda Cohn.// U.S. Food and Drug Administration. Retrieved April 21, 2022, from https://web.archive.org/web/20211108164042/https://www.fda.gov/media/136851/download))
+She attended [[Brown University]] where she received a Bachelor of Arts in English.((//CAPT Amanda Cohn.// U.S. Food and Drug Administration. Retrieved April 21, 2022, from https://web.archive.org/web/20211108164042/https://www.fda.gov/media/136851/download)) She obtained her medical degree from [[Emory University School of Medicine]] and completed a residency in pediatrics at [[Boston Children’s Hospital]] and [[Boston Medical Center]] in Massachusetts.((//Dr. Amanda Cohn Internal Medicine/Pediatrics. Atlanta GA.// WebMD. Retrieved April 21, 2022, from https://archive.ph/wQaBG)) ((Mead, A. (2021, May 12). //Vaccinating Rural America: Q&A with Dr. Amanda Cohn.// The Rural Monitor. https://www.ruralhealthinfo.org/rural-monitor/amanda-cohn-vaccination/))
+===== Career and Affiliations =====
+==== Centers for Disease Control and Prevention ====
+Cohn is the Director of the Division of Birth Defects and Infant Disorders under the [[Center for Disease Control and Prevention|US Centers for Disease Control and Prevention]] (CDC).((CDC. (2021, December 17). //Amanda Cohn | Biographies | About Us | NCBDDD | CDC.// Centers for Disease Control and Prevention. https://archive.ph/bixnF)) In this role, she acts as a liaison representative on the [[National Advisory Committee on Immunization]] (NACI), responsible for approving [[COVID-19 vaccines]] in Canada.((//National Advisory Committee on Immunization (NACI): Membership and representation.// (2020, December 18). Wayback Machine; Government of Canada. https://web.archive.org/web/20201218222110/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/naci-membership-representation.html))
+She previously served as Executive Secretariat of the [[Advisory Committee on Immunization Practices]] (ACIP) and Chief Medical Officer for the [[National Center for Immunization and Respiratory Diseases]] (NCIRD).((//CAPT Amanda Cohn.// U.S. Food and Drug Administration. Retrieved April 21, 2022, from https://web.archive.org/web/20211108164042/https://www.fda.gov/media/136851/download))
 Prior to that role, she served as the Acting Director for the [[National Center on Birth Defects and Developmental Disabilities]] and Deputy Director for Immunization Services Division for NCIRD.((//National Center on Birth Defects and Developmental Disabilities (NCBDDD)// (2020, February 3). Wayback Machine; Centers for Disease Control and Prevention. https://archive.ph/GRljJ)) ((//Capt. Amanda Cohn, MD.// (2021). University of New Mexico. https://web.archive.org/web/20210919091328/https://hsc.unm.edu/echo/_docs/covid-global-conversation/1.11.21_cohn_final1.pdf)) Dr. Cohn came to the CDC in 2004 as an [[Epidemic Intelligence Service]] Officer and joined the Meningitis and Vaccine Preventable Diseases Branch in 2006, where she focused on prevention and control [[meningococcal disease]], both domestically and internationally. From 2007 to 2014, she was the CDC lead for the ACIP Meningococcal Vaccines Work Group.
+She is the recipient of the CDC 2009 [[Iain Hardy Memorial Award]] for "outstanding contributions to vaccine-preventable diseases."((//ACIP Updates on Vaccine Recommendations.// (2017, November 4). Eventscribe. https://archive.ph/ZIcnE))
+==== U.S. Public Health Service ====
+Cohn is a Commander in the [[US Public Health Service]].((Cohn, A. (2011, April 6). //Amanda Cohn, MD CDR, US Public Health Service National Center for Immunization and Respiratory Diseases April 6, 2011 Epidemiology of Meningococcal Disease - [PPTX Powerpoint].// India Document. https://archive.ph/sjgym))
+==== Forum on Microbial Threats ====
+Cohn has participated numerous times on the planning committee for the [[Forum on Microbial Threats]], chaired by [[EcoHealth Alliance]] President [[Peter Daszak]].((//PLANNING COMMITTEE ON THE CRITICAL PUBLIC HEALTH VALUE OF VACCINES: TACKLING ISSUES OF ACCESS AND HESITANCY.// (2021). In www.ncbi.nlm.nih.gov. National Academies Press (US). https://www.ncbi.nlm.nih.gov/books/NBK572616/)) ((Forum on Microbial Threats. (2021). //The Critical Public Health Value of Vaccines// (J. Liao, C. Minicucci, & A. Nicholson, Eds.). National Academies Press. https://doi.org/10.17226/26134))
+===== Research =====
+==== Vaccines ====
+Cohn has co-authored research on [[meningococcal vaccines]].((Terranella, A., Cohn, A., & Clark. (2011). //Meningococcal conjugate vaccines: optimizing global impact.// Infection and Drug Resistance, 161. https://doi.org/10.2147/idr.s21545))
+==== COVID-19 ====
+Cohn was a co-author on the study identifying the first [[SARS-CoV-2]] infection in the United States, published in March 2020 in the [[New England Journal of Medicine]].((Holshue, M. L., DeBolt, C., Lindquist, S., Lofy, K. H., Wiesman, J., Bruce, H., Spitters, C., Ericson, K., Wilkerson, S., Tural, A., Diaz, G., Cohn, A., Fox, L., Patel, A., Gerber, S. I., Kim, L., Tong, S., Lu, X., Lindstrom, S., & Pallansch, M. A. (2020). //First Case of 2019 Novel Coronavirus in the United States.// New England Journal of Medicine, 382(10), 929–936. https://doi.org/10.1056/nejmoa2001191))
+===== External links =====
+  * [[https://wiki.whiteroseintelligence.com/en/Amanda-Cohn|White Rose Wiki]]